by Dennis Crouch Vanda is an important patent eligibility case drawing a fine line between the the eligible personalized medicine treatment claims and the ineligible methods of Mayo and Ariosa.  Vanda Pharma v. West-Ward Pharma (Fed. Cir. 2018) In a split decision, the Federal Circuit has affirmed the validity/infringement of Vanda’s U.S. Patent No. 8,586,610 covering … Continue reading Eligibility: Preamble Does the Trick for Federal Circuit